BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30037492)

  • 1. Patient reported outcomes in evaluation of chemotherapy toxicity in women with gynecologic malignancies: A pilot study.
    Webster EM; Burke WM; Ware HM; Jones BA; Vattakalam R; Tergas AI; Wright JD; Hou JY
    Gynecol Oncol; 2018 Sep; 150(3):487-493. PubMed ID: 30037492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gynecologic oncology patients' satisfaction and symptom severity during palliative chemotherapy.
    von Gruenigen VE; Hutchins JR; Reidy AM; Gibbons HE; Daly BJ; Eldermire EM; Fusco NL
    Health Qual Life Outcomes; 2006 Oct; 4():84. PubMed ID: 17074085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.
    Albaba H; Barnes TA; Veitch Z; Brown MC; Shakik S; Su S; Naik H; Wang T; Liang M; Perez-Cosio A; Eng L; Mittmann N; Xu W; Howell D; Liu G
    Oncologist; 2019 Nov; 24(11):e1219-e1227. PubMed ID: 31409744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HOPE Pilot Study: Harnessing Patient-Reported Outcomes and Biometric Data to Enhance Cancer Care.
    Wright AA; Raman N; Staples P; Schonholz S; Cronin A; Carlson K; Keating NL; Onnela JP
    JCO Clin Cancer Inform; 2018 Dec; 2():1-12. PubMed ID: 30652585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study.
    Zivanovic O; Chen LY; Vickers A; Straubhar A; Baser R; Veith M; Aiken N; Carter J; Curran K; Simon B; Mueller J; Jewell E; Chi DS; Sonoda Y; Abu-Rustum NR; Leitao MM
    Gynecol Oncol; 2020 Oct; 159(1):187-194. PubMed ID: 32718730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
    Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nursing intervention to enhance outpatient chemotherapy symptom management: Patient-reported outcomes of a randomized controlled trial.
    Traeger L; McDonnell TM; McCarty CE; Greer JA; El-Jawahri A; Temel JS
    Cancer; 2015 Nov; 121(21):3905-13. PubMed ID: 26194461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient online self-reporting of toxicity symptoms during chemotherapy.
    Basch E; Artz D; Dulko D; Scher K; Sabbatini P; Hensley M; Mitra N; Speakman J; McCabe M; Schrag D
    J Clin Oncol; 2005 May; 23(15):3552-61. PubMed ID: 15908666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective analysis of patient-reported outcomes and physician-reported outcomes with gynecologic cancer chemotherapy.
    Takenaga T; Kuji S; Tanabe KI; Kanamori R; Imai H; Takeuchi J; Kondo H; Ohara T; Iwatani T; Suzuki N
    J Obstet Gynaecol Res; 2024 Jan; 50(1):75-85. PubMed ID: 37852304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of leuprorelin for the treatment of recurrent gynecological cancer by assessment including self-administered quality-of-life questionnaire.
    Tsubamoto H; Ueda T; Inoue K; Isono-Nakata R; Saeki S; Kato Y; Shibahara H
    J Obstet Gynaecol Res; 2019 Jan; 45(1):203-209. PubMed ID: 30117238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative trajectory of patient reported symptoms: a pilot study in gynecologic oncology patients.
    Meyer LA; Nick AM; Shi Q; Wang XS; Williams L; Brock T; Iniesta MD; Rangel K; Lu KH; Ramirez PT
    Gynecol Oncol; 2015 Mar; 136(3):440-5. PubMed ID: 25647455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancer.
    Lee YC; Wang L; Kohn EC; Rubinstein L; Ivy SP; Harris PJ; Lheureux S
    Cancer; 2020 May; 126(10):2139-2145. PubMed ID: 32097505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and accessibility of electronic patient-reported outcome measures using a smartphone during routine chemotherapy: a pilot study.
    Bae WK; Kwon J; Lee HW; Lee SC; Song EK; Shim H; Ryu KH; Song J; Seo S; Yang Y; Park JH; Lee KH; Han HS
    Support Care Cancer; 2018 Nov; 26(11):3721-3728. PubMed ID: 29732483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported outcomes and chemotherapy-related cognitive impairment in gynecologic malignancy.
    Alimena S; Philp L; Orav EJ; Sullivan MW; Del Carmen M; Goodman A; Growdon WB; Bregar A; Eisenhauer E; Sisodia RC
    Int J Gynecol Cancer; 2022 Jun; 32(6):781-787. PubMed ID: 35169070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study.
    Hackbarth M; Haas N; Fotopoulou C; Lichtenegger W; Sehouli J
    Support Care Cancer; 2008 Mar; 16(3):267-73. PubMed ID: 17680280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of PRO in adverse event identification during cancer therapy - choosing the right questions to ask.
    Nissen A; Bager L; Pappot H
    Acta Oncol; 2019 May; 58(5):596-602. PubMed ID: 30702003
    [No Abstract]   [Full Text] [Related]  

  • 17. Danish Translation and Linguistic Validation of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
    Bæksted C; Nissen A; Pappot H; Bidstrup PE; Mitchell SA; Basch E; Dalton SO; Johansen C
    J Pain Symptom Manage; 2016 Aug; 52(2):292-7. PubMed ID: 27090851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging From the Haze: A Pilot Study Evaluating Feasibility of a Psychoeducational Intervention to Improve Cancer-Related Cognitive Impairment in Gynecologic Cancer Survivors.
    Liang MI; Erich B; Bailey C; Jo MY; Walsh CS; Asher A
    J Palliat Care; 2019 Jan; 34(1):32-37. PubMed ID: 30168368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electronic patient-reported outcomes from home in patients recovering from major gynecologic cancer surgery: A prospective study measuring symptoms and health-related quality of life.
    Cowan RA; Suidan RS; Andikyan V; Rezk YA; Einstein MH; Chang K; Carter J; Zivanovic O; Jewell EJ; Abu-Rustum NR; Basch E; Chi DS
    Gynecol Oncol; 2016 Nov; 143(2):362-366. PubMed ID: 27637366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Representations of fatigue in women receiving chemotherapy for gynecologic cancers.
    Donovan HS; Ward S
    Oncol Nurs Forum; 2005 Jan; 32(1):113-6. PubMed ID: 15660150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.